| Literature DB >> 32191775 |
Jing Wang1, Huanhuan Ma1, Shan Zhao1, Jianlei Huang1, Yihua Yang1, Bruce E Tabashnik2, Yidong Wu1.
Abstract
Evolution of pest resistance reduces the efficacy of insecticidal proteins from the gram-positive bacterium Bacillus thuringiensis (Bt) used widely in sprays and transgenic crops. Better understanding of the genetic basis of resistance is needed to more effectively monitor, manage, and counter pest resistance to Bt toxins. Here we used CRISPR/Cas9 gene editing to clarify the genetics of Bt resistance and the associated effects on susceptibility to other microbial insecticides in one of the world's most damaging pests, the cotton bollworm (Helicoverpa armigera). We discovered that CRISPR-mediated knockouts of ATP-binding cassette (ABC) transporter genes HaABCC2 and HaABCC3 together caused >15,000-fold resistance to Bt toxin Cry1Ac, whereas knocking out either HaABCC2 or HaABCC3 alone had little or no effect. Inheritance of resistance was autosomal and recessive. Bioassays of progeny from interstrain crosses revealed that one wild type allele of either HaABCC2 or HaABCC3 is sufficient to sustain substantial susceptibility to Cry1Ac. In contrast with previous results, susceptibility to two insecticides derived from bacteria other than Bt (abamectin and spinetoram), was not affected by knocking out HaABCC2, HaABCC3, or both. The results here provide the first evidence that either HaABCC2 or HaABCC3 protein is sufficient to confer substantial susceptibility to Cry1Ac. The functional redundancy of these two proteins in toxicity of Cry1Ac to H. armigera is expected to reduce the likelihood of field-evolved resistance relative to disruption of a toxic process where mutations affecting a single protein can confer resistance.Entities:
Year: 2020 PMID: 32191775 PMCID: PMC7108736 DOI: 10.1371/journal.ppat.1008427
Source DB: PubMed Journal: PLoS Pathog ISSN: 1553-7366 Impact factor: 6.823
Hatch rate and genotype frequencies during the creation of knockout strains.
| Strain | Hatch rate (G0) | Heterozygote frequency (G1) | Homozygote frequency (G2) |
|---|---|---|---|
| C2-KO | 24.2% (116/480) | 0.104 (10/96) | 0.100 (16/160) |
| C3-KO | 54.7% (173/316) | 0.068 (13/192) | 0.094 (9/96) |
| C2/3-KO | 49.3% (116/235) | 0.083 (8/96) | 0.211 (162/768) |
a (Neonates / eggs injected) X 100%.
Heterozygotes / total number of pupae screened.
c Homozygous mutants / total number of pupae and larvae screened; based on sequencing of all individuals screened for C2-KO and C3-KO, inferred from 21.1% survival at the diagnostic concentration and results showing that all 24 survivors sequenced were homozygous for the double knockout for C2/3-KO.
Primers used to identify mutations at four target sites.
| Target site | Primer name | Primer sequences (5’>3’) | Product size |
|---|---|---|---|
| C2-target 1 | TTGCTCCGCATGACTCAAGTGTC | ~210 bp | |
| C2-tar1-R | AAAATCAGTATAACGACTCCAAA | ||
| C2-target 2 | CGGACGCTTTGATCCAAAAGACG | ~230 bp | |
| C2-tar2-R | CCTCCATTAAGGTCCTTGTCATG | ||
| C3-target 1 | TGCGTATGAGCAACGGTTCCCTG | ~220 bp | |
| C3-tar1-R | TGGAAAGGCAGAGCAAGAGGAT | ||
| C3-target 2 | C3-tar2-F | CTGACAGCTTCATCCAGGAAACG | ~270 bp |
| CTTGCGTTTTCTTTCAGATTGCT |
a The primer underlined was used for direct sequencing.
Fig 1CRISPR/Cas9-mediated knockout of HaABCC2 and HaABCC3.
A) Genomic DNA. C2-sgRNA1 and C2-sgRNA2 target exons 4 and 24 in HaABCC2. C3-sgRNA1 and C3-sgRNA2 target exons 4 and 25 in the adjacent gene, HaABCC3. Boxes show exons and lines show introns. B) Protein structure for both HaABCC2 and HaABCC3. The number 1 shows the target sites of C2-sgRNA1 and C3-sgRNA1 in transmembrane (TM) region III; 2 shows the target sites of C2-sgRNA2 and C3-sgRNA2 near the carboxy terminus. C) Sequences of the wild type (WT) and knockouts (C2-KO, C3-KO, and C2/3-KO) detected in G1. Dashes show deleted bases and lower case letters show inserted bases. For HaABCC2, the same three knockout sequences occurred in C2-KO and C2/3-KO. For HaABCC3, one knockout sequence (large fragment missing) occurred in C3-KO and a different knockout sequence (two small fragments missing) occurred in C2/3-KO.
Responses to Cry1A toxins of the susceptible SCD strain and three knockout strains.
| Toxin | Strain | Slope ± SE | LC50 (95% FL | RR |
|---|---|---|---|---|
| Cry1Aa | SCD | 1.9 ± 0.18 | 0.16 (0.12–0.22) | 1.0 |
| C2-KO | 2.0 ± 0.18 | 0.14 (0.11–0.16) | 0.9 | |
| C3-KO | 2.2 ± 0.20 | 0.17 (0.12–0.21) | 1.1 | |
| C2/3-KO | — | >50 | >300 | |
| Cry1Ab | SCD | 2.1 ± 0.19 | 0.035 (0.026–0.047) | 1.0 |
| C2-KO | 1.8 ± 0.17 | 0.14 (0.10–0.19) | 4.0 | |
| C3-KO | 2.4 ± 0.21 | 0.034 (0.026–0.045) | 1.0 | |
| C2/3-KO | — | >50 | >1400 | |
| Cry1Ac | SCD | 1.9 ± 0.18 | 0.0053 (0.0043–0.0064) | 1.0 |
| C2-KO | 1.8 ± 0.17 | 0.020 (0.016–0.025) | 3.8 | |
| C3-KO | 2.1 ± 0.19 | 0.0047 (0.0033–0.0065) | 0.9 | |
| C2/3-KO | — | >80 | >15,000 |
a 95% fiducial limits, units are μg toxin per cm2 diet.
b Resistance ratio = LC50 of strain divided by LC50 of SCD for the same toxin.
c LC50 of the same toxin significantly greater for the knockout strain than SCD by the conservation criterion of no overlap of the 95% fiducial limits.
d The highest concentration tested (50 or 80 μg toxin per cm2 diet, as indicated above) killed less than 17% of larvae.
Fig 2Mortality of the susceptible strain (SCD), strains with one or two knockouts (C2-KO, C3-KO, and C2/3-KO), and progeny of various crosses in bioassays with Cry1Ac (0.05 μg Cry1Ac per cm2 diet).
Mortality was 100% for the first five strains and crosses at the left and 0% for C2/3-KO. Error bars show the upper limit of the 95% confidence interval. Asterisks indicate the two strains and two crosses with significantly lower mortality than SCD; P values from Fisher’s exact test: * = 0.014, ** = 0.0067, *** = 5 X 10−8 for C2/3-KO X C2-KO and 5 X 10−57 for C2/3-KO.
Responses to three insecticides of the susceptible SCD strain and three knockout strains.
| Insecticide | Strain | Slope ± SE | LC50 (95% FL | RR |
|---|---|---|---|---|
| Abamectin | SCD | 2.5 ± 0.24 | 0.076 (0.049–0.121) | 1.0 |
| C2-KO | 2.7 ± 0.25 | 0.074 (0.063–0.088) | 1.0 | |
| C3-KO | 2.9 ± 0.28 | 0.075 (0.056–0.100) | 1.0 | |
| C2/3-KO | 3.6 ± 0.38 | 0.073 (0.063–0.084) | 1.0 | |
| Spinetoram | SCD | 3.5 ± 0.34 | 0.25 (0.22–0.29) | 1.0 |
| C2-KO | 3.2 ± 0.30 | 0.24 (0.19–0.30) | 1.0 | |
| C3-KO | 3.3 ± 0.31 | 0.25 (0.22–0.29) | 1.0 | |
| C2/3-KO | 2.8 ± 0.26 | 0.24 (0.20–0.28) | 1.0 | |
| Chlorantraniliprole | SCD | 3.4 ± 0.35 | 0.30 (0.26–0.35) | 1.0 |
| C2-KO | 3.3 ± 0.33 | 0.34 (0.29–0.40) | 1.1 | |
| C3-KO | 2.9 ± 0.28 | 0.37 (0.32–0.44) | 1.2 | |
| C2/3-KO | 3.3 ± 0.33 | 0.31 (0.27–0.36) | 1.0 |
a 95% fiducial limits, units are mg per liter.
b Resistance ratio = LC50 of strain divided by LC50 of SCD.
Fig 3Proposed model for the toxic pathway of Cry1Ac against H. armigera based on results from CRISPR-mediated editing of HaABCC2 and HaABCC3 in this study, and of HaCad [47].